Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib - Physician's Weekly

Retrieved on: 2024-02-27 07:01:54

Tags for this article:

COVID-19 drug development

Nitriles

Baricitinib

Remdesivir

Treatment and management of COVID-19

STAT

Sarah Pett

Click the tags to see associated articles and topics

Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib - Physician's Weekly. View article details on hiswai:

Excerpt

Compared with control participants, those receiving baricitinib plus remdesivir had significantly larger increases in absolute lymphocyte count and ...

Article found on: www.physiciansweekly.com

View Original Article